Equity of the Meningitis B vaccination programme in England, 2016-2018
- PMID: 36117004
- DOI: 10.1016/j.vaccine.2022.09.023
Equity of the Meningitis B vaccination programme in England, 2016-2018
Abstract
In England, the Meningitis B (MenB) vaccine is scheduled at eight and 16 weeks with a booster dose at one year of age and protects children against invasive bacterial meningococcal disease caused by Neisseria meningitidis serogroup B. Coverage of the second dose of MenB vaccine at 12 months was >92% in 2017/18, but this may mask inequalities in coverage in particular population groups. MenB vaccination records for children aged six, 12 and 18 months of age from December 2016 to May 2018 were routinely extracted from GP patient management systems every month in England via a web-based platform for national monitoring of vaccine coverage. We determined the association between ethnicity, deprivation and area of residence, vaccine coverage and drop-out rates (between dose one and dose two), using binomial regression. After adjusting for other factors, ethnic groups with lowest dose one coverage (Black or Black British-Caribbean, White-Any other White background, White-Irish) also had lowest dose two coverage, but in addition, these ethnic groups also had the largest drop-out rates between dose one and dose two. The drop-out rate for Black or Black British-Caribbean children was 5.7 percentage points higher than for White-British children. Vaccine coverage decreased with increasing deprivation quintile, and this was most marked for the booster coverage (6.2 percentage points lower in the most deprived compared to least deprived quintile, p < 0.001). To achieve high coverage for completed courses across all ethnic groups and deprivation quintiles both high initiation rates and a reduction in drop-out rates for ethnic groups with lowest coverage is necessary. A qualitative approach to better understand reasons behind lower coverage and higher drop-out rates in the most underserved ethnic groups is required to develop tailored approaches addressing these inequalities.
Keywords: Coverage; Ethnicity; Immunisation; Inequality; Meningitis B; Vaccination.
Crown Copyright © 2022. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.BMJ Open. 2020 Oct 22;10(10):e037358. doi: 10.1136/bmjopen-2020-037358. BMJ Open. 2020. PMID: 33093030 Free PMC article.
-
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland.mSphere. 2018 Aug 22;3(4):e00196-18. doi: 10.1128/mSphere.00196-18. mSphere. 2018. PMID: 30135218 Free PMC article.
-
Vaccines against Neisseria meningitidis serogroup B strains - What does genomics reveal on the Portuguese strain's coverage.Vaccine. 2022 Aug 5;40(33):4772-4779. doi: 10.1016/j.vaccine.2022.06.038. Epub 2022 Jun 29. Vaccine. 2022. PMID: 35778280
-
The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme--New challenges for public health.J Infect. 2015 Dec;71(6):611-4. doi: 10.1016/j.jinf.2015.09.035. Epub 2015 Oct 2. J Infect. 2015. PMID: 26433141 Review.
-
A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp.J Clin Pharm Ther. 2020 Apr;45(2):270-281. doi: 10.1111/jcpt.13083. Epub 2019 Dec 9. J Clin Pharm Ther. 2020. PMID: 31820483 Review.
Cited by
-
Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era.Vaccines (Basel). 2023 Mar 17;11(3):680. doi: 10.3390/vaccines11030680. Vaccines (Basel). 2023. PMID: 36992264 Free PMC article.
-
Understanding the health system barriers and enablers to childhood MMR and HPV vaccination among disadvantaged, minority or underserved populations in middle- and high-income countries: a systematic review.Eur J Public Health. 2024 Apr 3;34(2):368-374. doi: 10.1093/eurpub/ckad232. Eur J Public Health. 2024. PMID: 38183166 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical